DrugCards

DrugCards DrugCard is a cost-effective full-regulatory compliant software for pharma drug safety departments

๐Ÿ•ถ๏ธ๐— ๐—ฎ๐˜€๐—ธ๐—ถ๐—ป๐—ด ๐—ฝ๐—ฒ๐—ฟ๐˜€๐—ผ๐—ป๐—ฎ๐—น ๐—ฑ๐—ฎ๐˜๐—ฎ ๐—ถ๐—ป ๐—ฝ๐—ต๐—ฎ๐—ฟ๐—บ๐—ฎ๐—ฐ๐—ผ๐˜ƒ๐—ถ๐—ด๐—ถ๐—น๐—ฎ๐—ป๐—ฐ๐—ฒ: ๐—ฝ๐—ฟ๐—ถ๐˜ƒ๐—ฎ๐—ฐ๐˜† ๐˜ƒ๐˜€. ๐—ฝ๐—ฎ๐˜๐—ถ๐—ฒ๐—ป๐˜ ๐˜€๐—ฎ๐—ณ๐—ฒ๐˜๐˜†Not all details in ICSRs should be visible - and...
19/08/2025

๐Ÿ•ถ๏ธ๐— ๐—ฎ๐˜€๐—ธ๐—ถ๐—ป๐—ด ๐—ฝ๐—ฒ๐—ฟ๐˜€๐—ผ๐—ป๐—ฎ๐—น ๐—ฑ๐—ฎ๐˜๐—ฎ ๐—ถ๐—ป ๐—ฝ๐—ต๐—ฎ๐—ฟ๐—บ๐—ฎ๐—ฐ๐—ผ๐˜ƒ๐—ถ๐—ด๐—ถ๐—น๐—ฎ๐—ป๐—ฐ๐—ฒ: ๐—ฝ๐—ฟ๐—ถ๐˜ƒ๐—ฎ๐—ฐ๐˜† ๐˜ƒ๐˜€. ๐—ฝ๐—ฎ๐˜๐—ถ๐—ฒ๐—ป๐˜ ๐˜€๐—ฎ๐—ณ๐—ฒ๐˜๐˜†
Not all details in ICSRs should be visible - and not all should be hidden.
Since July 2025, the ๐Ÿ‡ช๐Ÿ‡บEMA has enforced new rules on handling personal data in ICSRs. Some fields must be masked, some left blank, and others remain visible - because patient safety depends on it.

๐Ÿ’กThe new EMA guidance on masking of personal data in pharmacovigilance changes the way we balance data protection with drug safety.
๐Ÿ“– Read our latest DrugCard blog to learn what MAHs and PV specialists must know: https://drug-card.io/blog/masking-of-personal-data-in-pharmacovigilance/

๐—ช๐—ต๐˜† ๐——๐—ฟ๐˜‚๐—ด ๐—œ๐—ป๐—ณ๐˜‚๐˜€๐—ถ๐—ผ๐—ป ๐—ฆ๐—ฝ๐—ฒ๐—ฒ๐—ฑ ๐— ๐—ถ๐—ด๐—ต๐˜ ๐—•๐—ฒ ๐—ฌ๐—ผ๐˜‚๐—ฟ ๐—•๐—น๐—ถ๐—ป๐—ฑ ๐—ฆ๐—ฝ๐—ผ๐˜ ๐—ถ๐—ป ๐—”๐——๐—ฅ๐˜€In pharmacovigilance, we track what drugs patients take, when, a...
12/08/2025

๐—ช๐—ต๐˜† ๐——๐—ฟ๐˜‚๐—ด ๐—œ๐—ป๐—ณ๐˜‚๐˜€๐—ถ๐—ผ๐—ป ๐—ฆ๐—ฝ๐—ฒ๐—ฒ๐—ฑ ๐— ๐—ถ๐—ด๐—ต๐˜ ๐—•๐—ฒ ๐—ฌ๐—ผ๐˜‚๐—ฟ ๐—•๐—น๐—ถ๐—ป๐—ฑ ๐—ฆ๐—ฝ๐—ผ๐˜ ๐—ถ๐—ป ๐—”๐——๐—ฅ๐˜€
In pharmacovigilance, we track what drugs patients take, when, and how much. But how often do we consider how fast the drug ๐Ÿ’‰is infused?

๐ŸšจInfusion rate can be the difference between a routine therapy and a sudden, life-threatening reaction. Yet, most ADR reports donโ€™t capture this crucial detail - meaning critical clues to causality may slip through the cracks.

๐Ÿ’กRead more in our new blog post โ€“ https://drug-card.io/blog/drug-infusion-rate-and-how-speed-affects-adrs/

๐——๐—ฟ๐˜‚๐—ด ๐——๐—ถ๐˜€๐—ฐ๐—ผ๐—ป๐˜๐—ถ๐—ป๐˜‚๐—ฎ๐˜๐—ถ๐—ผ๐—ป ๐—œ๐˜€๐—ปโ€™๐˜ ๐—”๐—น๐˜„๐—ฎ๐˜†๐˜€ ๐—ฆ๐—ฎ๐—ณ๐—ฒMost of us think about drug safety in terms of side effects while taking ๐Ÿ’Šmedicati...
05/08/2025

๐——๐—ฟ๐˜‚๐—ด ๐——๐—ถ๐˜€๐—ฐ๐—ผ๐—ป๐˜๐—ถ๐—ป๐˜‚๐—ฎ๐˜๐—ถ๐—ผ๐—ป ๐—œ๐˜€๐—ปโ€™๐˜ ๐—”๐—น๐˜„๐—ฎ๐˜†๐˜€ ๐—ฆ๐—ฎ๐—ณ๐—ฒ
Most of us think about drug safety in terms of side effects while taking ๐Ÿ’Šmedications. But what happens when a patient stops a drug - sometimes abruptly, without medical advice?

Drug discontinuation ๐Ÿšซabruptly can cause serious risks like withdrawal and rebound effects, which are often overlooked in drug safety. For pharmacovigilance specialists, monitoring doesnโ€™t end at the last dose.

๐Ÿ”ฅCheck out our latest blog post on the DrugCard platform to learn more ๐Ÿ‘‰ https://drug-card.io/blog/drug-discontinuation-needs-more-attention-in-drug-safety-monitoring/

๐—ฃ๐—ฟ๐—ฒ๐—ฐ๐—ฎ๐˜‚๐˜๐—ถ๐—ผ๐—ป๐—ฎ๐—ฟ๐˜† ๐—บ๐—ฒ๐—ฎ๐˜€๐˜‚๐—ฟ๐—ฒ๐˜€ ๐—ถ๐—ป ๐—ฝ๐—ต๐—ฎ๐—ฟ๐—บ๐—ฎ๐—ฐ๐—ผ๐˜ƒ๐—ถ๐—ด๐—ถ๐—น๐—ฎ๐—ป๐—ฐ๐—ฒ ๐—ฎ๐—ฟ๐—ฒ๐—ปโ€™๐˜ ๐—ท๐˜‚๐˜€๐˜ ๐—ฝ๐—ฟ๐—ผ๐˜๐—ผ๐—ฐ๐—ผ๐—น๐˜€ - ๐˜๐—ต๐—ฒ๐˜† ๐˜€๐—ฎ๐˜ƒ๐—ฒ ๐—น๐—ถ๐˜ƒ๐—ฒ๐˜€.In pharmacovigilance, waiting for pe...
29/07/2025

๐—ฃ๐—ฟ๐—ฒ๐—ฐ๐—ฎ๐˜‚๐˜๐—ถ๐—ผ๐—ป๐—ฎ๐—ฟ๐˜† ๐—บ๐—ฒ๐—ฎ๐˜€๐˜‚๐—ฟ๐—ฒ๐˜€ ๐—ถ๐—ป ๐—ฝ๐—ต๐—ฎ๐—ฟ๐—บ๐—ฎ๐—ฐ๐—ผ๐˜ƒ๐—ถ๐—ด๐—ถ๐—น๐—ฎ๐—ป๐—ฐ๐—ฒ ๐—ฎ๐—ฟ๐—ฒ๐—ปโ€™๐˜ ๐—ท๐˜‚๐˜€๐˜ ๐—ฝ๐—ฟ๐—ผ๐˜๐—ผ๐—ฐ๐—ผ๐—น๐˜€ - ๐˜๐—ต๐—ฒ๐˜† ๐˜€๐—ฎ๐˜ƒ๐—ฒ ๐—น๐—ถ๐˜ƒ๐—ฒ๐˜€.
In pharmacovigilance, waiting for perfect data can cost lives. Thatโ€™s why precautionary measures - early, decisive steps taken by regulatory authorities - are essential to managing emerging ๐Ÿ’Šdrug safety risks.

๐Ÿ”ฅOur latest blog post on the DrugCard platform explores a compelling real-world example where global agencies swiftly responded to serious adverse events linked to a vaccine, protecting vulnerable ๐Ÿ‘ต๐Ÿปpopulations while investigations were ongoing.
๐Ÿ”— https://drug-card.io/blog/precautionary-measures-in-pv-show-how-safety-comes-first/
๐Ÿ’ชStay informed and learn why early, decisive action is key to drug safety.

๐—ก๐—ผ๐—ฐ๐—ฒ๐—ฏ๐—ผ ๐—˜๐—ณ๐—ณ๐—ฒ๐—ฐ๐˜ ๐— ๐—ถ๐˜€๐—น๐—ฒ๐—ฎ๐—ฑ๐˜€ ๐—”๐——๐—ฅ ๐——๐—ฒ๐˜๐—ฒ๐—ฐ๐˜๐—ถ๐—ผ๐—ปNot all adverse๐Ÿ’Š drug reactions come from the drug itself.๐Ÿ“„The latest article on the...
22/07/2025

๐—ก๐—ผ๐—ฐ๐—ฒ๐—ฏ๐—ผ ๐—˜๐—ณ๐—ณ๐—ฒ๐—ฐ๐˜ ๐— ๐—ถ๐˜€๐—น๐—ฒ๐—ฎ๐—ฑ๐˜€ ๐—”๐——๐—ฅ ๐——๐—ฒ๐˜๐—ฒ๐—ฐ๐˜๐—ถ๐—ผ๐—ป
Not all adverse๐Ÿ’Š drug reactions come from the drug itself.

๐Ÿ“„The latest article on the DrugCard platform blog dives into the nocebo effect - how patient ๐Ÿง expectations can mimic real adverse drug reactions, complicate pharmacovigilance, and lead to therapy failure: https://drug-card.io/blog/nocebo-effect-or-when-the-mind-becomes-the-side-effect/

๐Ÿ’กThis psychological phenomenon is more common than you think - and itโ€™s quietly impacting drug safety data.

๐—”๐—ฑ๐—ฑ๐—ฒ๐—ป๐—ฑ๐˜‚๐—บ ๐˜๐—ผ ๐˜๐—ต๐—ฒ ๐—–๐—น๐—ถ๐—ป๐—ถ๐—ฐ๐—ฎ๐—น ๐—ข๐˜ƒ๐—ฒ๐—ฟ๐˜ƒ๐—ถ๐—ฒ๐˜„ ๐—ฎ๐˜€ ๐—ฎ ๐—š๐—ฟ๐—ผ๐˜„๐˜๐—ต ๐——๐—ถ๐—ฎ๐—ฟ๐˜† ๐—ณ๐—ผ๐—ฟ ๐— ๐—ฒ๐—ฑ๐—ถ๐—ฐ๐—ถ๐—ป๐—ฒ๐˜€๐Ÿ’ŠPreparing an ACO isn't just regulatory - it's storytel...
15/07/2025

๐—”๐—ฑ๐—ฑ๐—ฒ๐—ป๐—ฑ๐˜‚๐—บ ๐˜๐—ผ ๐˜๐—ต๐—ฒ ๐—–๐—น๐—ถ๐—ป๐—ถ๐—ฐ๐—ฎ๐—น ๐—ข๐˜ƒ๐—ฒ๐—ฟ๐˜ƒ๐—ถ๐—ฒ๐˜„ ๐—ฎ๐˜€ ๐—ฎ ๐—š๐—ฟ๐—ผ๐˜„๐˜๐—ต ๐——๐—ถ๐—ฎ๐—ฟ๐˜† ๐—ณ๐—ผ๐—ฟ ๐— ๐—ฒ๐—ฑ๐—ถ๐—ฐ๐—ถ๐—ป๐—ฒ๐˜€๐Ÿ’Š
Preparing an ACO isn't just regulatory - it's storytelling.
It's where we tell the story of a drug: how it grew, what challenges it faced, and how safe and effective it remained over time. It's almost like describing a ๐Ÿ‘ถchild's development - only with clinical trials, PSURs, and global safety data.

๐Ÿ“Our latest blog post explores why the ACO is essential for MA renewals and variations: https://drug-card.io/blog/addendum-to-the-clinical-overview-supporting-safety-decisions/

๐Ÿ“And don't forget: innovative and intelligent tools make the process easier. With ๐™Ž๐™ž๐™ข๐™ฅ๐™ก๐™š ๐™Ž๐™š๐™–๐™ง๐™˜๐™ ๐™—๐™ฎ ๐˜ฟ๐™ง๐™ช๐™œ๐˜พ๐™–๐™ง๐™™๐Ÿ”ฅ, specialists can quickly find relevant literature to support safety assessments.

๐—™๐—ผ๐—ฟ๐—ฒ๐—ถ๐—ด๐—ป ๐—Ÿ๐—ฎ๐—ป๐—ด๐˜‚๐—ฎ๐—ด๐—ฒ ๐—ฆ๐˜†๐—ป๐—ฑ๐—ฟ๐—ผ๐—บ๐—ฒ ๐—ผ๐—ฟ ๐—๐˜‚๐˜€๐˜ ๐—ฎ ๐—ฆ๐—ถ๐—ฑ๐—ฒ ๐—˜๐—ณ๐—ณ๐—ฒ๐—ฐ๐˜?A man with no real-life English skills suddenly speaks fluent English - ...
08/07/2025

๐—™๐—ผ๐—ฟ๐—ฒ๐—ถ๐—ด๐—ป ๐—Ÿ๐—ฎ๐—ป๐—ด๐˜‚๐—ฎ๐—ด๐—ฒ ๐—ฆ๐˜†๐—ป๐—ฑ๐—ฟ๐—ผ๐—บ๐—ฒ ๐—ผ๐—ฟ ๐—๐˜‚๐˜€๐˜ ๐—ฎ ๐—ฆ๐—ถ๐—ฑ๐—ฒ ๐—˜๐—ณ๐—ณ๐—ฒ๐—ฐ๐˜?
A man with no real-life English skills suddenly speaks fluent English - during a drug ๐Ÿ’Šreaction.

๐Ÿค”Is it psychosis? Possession? Or a rare ADR called foreign language syndrome?

โ—๏ธOur latest DrugCard blog dives into one of the strangest pharmacovigilance cases youโ€™ll ever read.

๐Ÿ“– Read more: https://drug-card.io/blog/foreign-language-syndrome-or-when-adrs-speak-another-language/

๐Ÿค”๐—”๐—ฟ๐—ฒ ๐—ต๐—ผ๐—บ๐—ฒ๐—ผ๐—ฝ๐—ฎ๐˜๐—ต๐—ถ๐—ฐ ๐—บ๐—ฒ๐—ฑ๐—ถ๐—ฐ๐—ถ๐—ป๐—ฒ๐˜€ ๐—ฟ๐—ถ๐˜€๐—ธ-๐—ณ๐—ฟ๐—ฒ๐—ฒ?Our latest blog post explores the surprising truth behind their safety profile.๐ŸซงHom...
01/07/2025

๐Ÿค”๐—”๐—ฟ๐—ฒ ๐—ต๐—ผ๐—บ๐—ฒ๐—ผ๐—ฝ๐—ฎ๐˜๐—ต๐—ถ๐—ฐ ๐—บ๐—ฒ๐—ฑ๐—ถ๐—ฐ๐—ถ๐—ป๐—ฒ๐˜€ ๐—ฟ๐—ถ๐˜€๐—ธ-๐—ณ๐—ฟ๐—ฒ๐—ฒ?
Our latest blog post explores the surprising truth behind their safety profile.

๐ŸซงHomeopathy is often seen as harmless, but rare adverse reactions still happen. This article explains why pharmacovigilance must also include alternative medicines.

๐Ÿ‘‰Read now and rethink what โ€œsafeโ€ really means: https://drug-card.io/blog/homeopathic-medicines-and-a-risk-no-one-saw-coming/

๐Ÿ“‘๐—”๐—ฟ๐—ฒ ๐—ฌ๐—ผ๐˜‚๐—ฟ ๐—–๐—ผ๐—ฟ๐—ฒ ๐—ฃ๐—ต๐—ฎ๐—ฟ๐—บ๐—ฎ๐—ฐ๐—ผ๐˜ƒ๐—ถ๐—ด๐—ถ๐—น๐—ฎ๐—ป๐—ฐ๐—ฒ ๐——๐—ผ๐—ฐ๐˜‚๐—บ๐—ฒ๐—ป๐˜๐˜€ ๐—”๐˜‚๐—ฑ๐—ถ๐˜-๐—ฅ๐—ฒ๐—ฎ๐—ฑ๐˜†?In PV, documentation is your first line of defense.๐Ÿ’กFrom ICSRs to...
24/06/2025

๐Ÿ“‘๐—”๐—ฟ๐—ฒ ๐—ฌ๐—ผ๐˜‚๐—ฟ ๐—–๐—ผ๐—ฟ๐—ฒ ๐—ฃ๐—ต๐—ฎ๐—ฟ๐—บ๐—ฎ๐—ฐ๐—ผ๐˜ƒ๐—ถ๐—ด๐—ถ๐—น๐—ฎ๐—ป๐—ฐ๐—ฒ ๐——๐—ผ๐—ฐ๐˜‚๐—บ๐—ฒ๐—ป๐˜๐˜€ ๐—”๐˜‚๐—ฑ๐—ถ๐˜-๐—ฅ๐—ฒ๐—ฎ๐—ฑ๐˜†?
In PV, documentation is your first line of defense.

๐Ÿ’กFrom ICSRs to PSURs, from RMPs to the PSMF - each one plays a critical role. Miss one, and your entire compliance system could be at risk.

๐Ÿง Our new DrugCard blog post covers the Top 5 Core Pharmacovigilance Documents every safety team must have in place.

๐Ÿ‘‰ Learn more: https://drug-card.io/blog/top-5-core-pharmacovigilance-documents-you-shouldn-t-forget/

๐—ฆ๐˜๐—ถ๐—น๐—น ๐—ต๐—ฎ๐—ป๐—ฑ๐—น๐—ถ๐—ป๐—ด ๐—ฎ๐—ฑ๐˜ƒ๐—ฒ๐—ฟ๐˜€๐—ฒ ๐—ฑ๐—ฟ๐˜‚๐—ด ๐—ฟ๐—ฒ๐—ฎ๐—ฐ๐˜๐—ถ๐—ผ๐—ป ๐—ฟ๐—ฒ๐—ฝ๐—ผ๐—ฟ๐˜๐˜€ ๐˜๐—ต๐—ฒ ๐—ผ๐—น๐—ฑ-๐—ณ๐—ฎ๐˜€๐—ต๐—ถ๐—ผ๐—ป๐—ฒ๐—ฑ ๐˜„๐—ฎ๐˜†?What if ๐ŸฆพAI could write your case narrative, generate...
17/06/2025

๐—ฆ๐˜๐—ถ๐—น๐—น ๐—ต๐—ฎ๐—ป๐—ฑ๐—น๐—ถ๐—ป๐—ด ๐—ฎ๐—ฑ๐˜ƒ๐—ฒ๐—ฟ๐˜€๐—ฒ ๐—ฑ๐—ฟ๐˜‚๐—ด ๐—ฟ๐—ฒ๐—ฎ๐—ฐ๐˜๐—ถ๐—ผ๐—ป ๐—ฟ๐—ฒ๐—ฝ๐—ผ๐—ฟ๐˜๐˜€ ๐˜๐—ต๐—ฒ ๐—ผ๐—น๐—ฑ-๐—ณ๐—ฎ๐˜€๐—ต๐—ถ๐—ผ๐—ป๐—ฒ๐—ฑ ๐˜„๐—ฎ๐˜†?
What if ๐ŸฆพAI could write your case narrative, generate your ICSR, and spot unlisted reactions faster than you can say "expectedness"?

๐Ÿง Our latest article explores 5๏ธโƒฃ smart strategies for transforming pharmacovigilance teams' management of ADRs - from automation to risk-based triage.

๐Ÿ‘‰ See how modern tools like DrugCard are reshaping drug safety workflows: https://drug-card.io/blog/5-smart-ways-to-streamline-handling-adverse-drug-reaction-reports/

๐— ๐—ฒ๐—ฑ๐—ถ๐—ฐ๐—ถ๐—ป๐—ฒ ๐—ฆ๐—ต๐—ผ๐—ฟ๐˜๐—ฎ๐—ด๐—ฒ๐˜€ ๐—ผ๐—ฟ ๐—ช๐—ต๐—ฒ๐—ป ๐——๐—ฟ๐˜‚๐—ด ๐—ฆ๐—ฎ๐—ณ๐—ฒ๐˜๐˜† ๐—˜๐—บ๐—ฝ๐˜๐—ถ๐—ฒ๐˜€ ๐˜๐—ต๐—ฒ ๐—ฃ๐—ต๐—ฎ๐—ฟ๐—บ๐—ฎ๐—ฐ๐˜† ๐ŸฅMedicine shortages? Most think itโ€™s just logistics or suppl...
10/06/2025

๐— ๐—ฒ๐—ฑ๐—ถ๐—ฐ๐—ถ๐—ป๐—ฒ ๐—ฆ๐—ต๐—ผ๐—ฟ๐˜๐—ฎ๐—ด๐—ฒ๐˜€ ๐—ผ๐—ฟ ๐—ช๐—ต๐—ฒ๐—ป ๐——๐—ฟ๐˜‚๐—ด ๐—ฆ๐—ฎ๐—ณ๐—ฒ๐˜๐˜† ๐—˜๐—บ๐—ฝ๐˜๐—ถ๐—ฒ๐˜€ ๐˜๐—ต๐—ฒ ๐—ฃ๐—ต๐—ฎ๐—ฟ๐—บ๐—ฎ๐—ฐ๐˜† ๐Ÿฅ
Medicine shortages? Most think itโ€™s just logistics or supply chains. But what if the real cause is hidden in a pharmacovigilance report?

๐Ÿค”From unexpected adverse reactions to missing safety updates, one case report can sometimes trigger a cascade that leaves patients without treatment๐Ÿ’Š.

A suspended license today means an empty shelf tomorrow.
๐Ÿ‘‰Read the full story here: https://drug-card.io/blog/medicine-shortages-when-the-pharmacy-shelf-is-empty/

๐—ก๐—ผ๐˜ ๐—ฎ๐—น๐—น ๐—ฎ๐—ฑ๐˜ƒ๐—ฒ๐—ฟ๐˜€๐—ฒ ๐—ฟ๐—ฒ๐—ฎ๐—ฐ๐˜๐—ถ๐—ผ๐—ป๐˜€ ๐—ฐ๐—ผ๐—บ๐—ฒ ๐—ณ๐—ฟ๐—ผ๐—บ ๐—ฑ๐—ฟ๐˜‚๐—ด๐˜€๐Ÿ’ŠOur latest blog post dives into real-life cases of non-drug reactions - from a...
03/06/2025

๐—ก๐—ผ๐˜ ๐—ฎ๐—น๐—น ๐—ฎ๐—ฑ๐˜ƒ๐—ฒ๐—ฟ๐˜€๐—ฒ ๐—ฟ๐—ฒ๐—ฎ๐—ฐ๐˜๐—ถ๐—ผ๐—ป๐˜€ ๐—ฐ๐—ผ๐—บ๐—ฒ ๐—ณ๐—ฟ๐—ผ๐—บ ๐—ฑ๐—ฟ๐˜‚๐—ด๐˜€๐Ÿ’Š
Our latest blog post dives into real-life cases of non-drug reactions - from a TikTok โ€œremedyโ€ that sent a teen to the ER to kidney failure caused by cotton phenol exposure and even a DRESS-like syndrome triggered by shiitake mushrooms. ๐Ÿ„

๐Ÿ“– Curious? Read the full article on the DrugCard blog: https://drug-card.io/blog/non-drug-reactions-that-surprise-medical-experts/
Let us know which case surprised you most!

Address


Alerts

Be the first to know and let us send you an email when DrugCards posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to DrugCards:

  • Want your practice to be the top-listed Clinic?

Share